Summit Rock Advisors, LP Q3 2022 holdings

$128 Million is the total value of Summit Rock Advisors, LP's 5 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 62.5% .

 Value Shares↓ Weighting
XLE BuySELECT SECTOR SPDR TRenergy$78,113
+29.5%
1,084,604
+28.6%
60.96%
+23.7%
IWN SellISHARES TRrus 2000 val etf$43,689
-23.6%
338,862
-19.3%
34.10%
-27.0%
VT BuyVANGUARD INTL EQUITY INDEX Ftt wrld st etf$5,253
+96.4%
66,600
+112.6%
4.10%
+87.6%
NewPLANET LABS PBC$559102,880
+100.0%
0.44%
DAWN SellDAY ONE BIOPHARMACEUTICALS I$516
-13.0%
25,751
-22.3%
0.40%
-16.7%
DYN ExitDYNE THERAPEUTICS INC$0-34,887
-100.0%
-0.20%
PHAT ExitPHATHOM PHARMACEUTICALS INC$0-34,100
-100.0%
-0.24%
CLOV ExitCLOVER HEALTH INVESTMENTS CO$0-210,639
-100.0%
-0.37%
WMS ExitADVANCED DRAIN SYS INC DEL$0-7,448
-100.0%
-0.55%

Filings

The following EDGAR filing(s) were analyzed to create this report:

Signatures

The EDGAR filing(s) were signed by:

  • Asher Ailey — Chief Compliance Officer

Compare quarterly holdings

Export Summit Rock Advisors, LP's holdings

EDGAR filings